A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)

NCT07640984 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis IIIB

Interventions

DRUG: JR-446

Sponsor

JCR Pharmaceuticals Co., Ltd.

Collaborators

[object Object]